2024 Q2 Form 10-Q Financial Statement
#000162828024022619 Filed on May 10, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 | 2023 Q1 |
---|---|---|---|
Revenue | $459.7M | $431.7M | $390.6M |
YoY Change | 13.87% | 10.53% | 14.28% |
Cost Of Revenue | $343.6M | $343.5M | $315.6M |
YoY Change | 9.03% | 8.82% | 12.53% |
Gross Profit | $116.2M | $88.23M | $74.94M |
YoY Change | 31.08% | 17.74% | 22.28% |
Gross Profit Margin | 25.27% | 20.44% | 19.19% |
Selling, General & Admin | $29.90M | $28.83M | $28.95M |
YoY Change | -0.51% | -0.43% | -2.27% |
% of Gross Profit | 25.74% | 32.67% | 38.63% |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $34.48M | $32.37M | $31.32M |
YoY Change | 7.13% | 3.36% | 15.48% |
% of Gross Profit | 29.68% | 36.69% | 41.79% |
Operating Expenses | $424.9M | $420.4M | $383.9M |
YoY Change | 12.02% | 9.5% | 11.76% |
Operating Profit | $34.85M | $11.34M | $6.671M |
YoY Change | 42.57% | 69.97% | -488.07% |
Interest Expense | -$24.58M | -$10.73M | -$18.39M |
YoY Change | 135.09% | -41.66% | -256.58% |
% of Operating Profit | -70.55% | -94.6% | -275.63% |
Other Income/Expense, Net | -$25.45M | -$7.793M | -$19.82M |
YoY Change | 142.4% | -60.68% | -271.18% |
Pretax Income | $9.401M | $3.546M | -$13.15M |
YoY Change | -32.58% | -126.97% | -233.36% |
Income Tax | $2.500M | -$1.900M | $1.100M |
% Of Pretax Income | 26.59% | -53.58% | |
Net Earnings | -$2.982M | -$2.779M | -$21.01M |
YoY Change | -135.63% | -86.77% | -797.15% |
Net Earnings / Revenue | -0.65% | -0.64% | -5.38% |
Basic Earnings Per Share | -$0.04 | -$0.04 | -$0.36 |
Diluted Earnings Per Share | -$0.04 | -$0.04 | -$0.36 |
COMMON SHARES | |||
Basic Shares Outstanding | 73.88M shares | 68.48M shares | 57.84M shares |
Diluted Shares Outstanding | 73.42M shares | 69.31M shares | 57.70M shares |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 | 2023 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $741.7M | $527.0M | $90.84M |
YoY Change | 107.96% | 480.09% | 28.47% |
Cash & Equivalents | $741.7M | $527.0M | $90.84M |
Short-Term Investments | |||
Other Short-Term Assets | $38.54M | $45.01M | $55.10M |
YoY Change | -21.86% | -18.32% | 5.0% |
Inventory | |||
Prepaid Expenses | |||
Receivables | $195.3M | $189.6M | $176.4M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $1.005B | $795.8M | $342.7M |
YoY Change | 66.71% | 132.23% | 18.7% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $652.9M | $618.9M | $545.5M |
YoY Change | 13.33% | 13.46% | 11.56% |
Goodwill | $709.0M | $694.3M | $687.1M |
YoY Change | 3.07% | 1.05% | 20.5% |
Intangibles | $84.05M | $86.88M | $103.0M |
YoY Change | -16.31% | -15.65% | 3.69% |
Long-Term Investments | $9.200M | $9.200M | $59.32M |
YoY Change | -82.47% | -84.49% | 32.57% |
Other Assets | $53.86M | $54.98M | $53.17M |
YoY Change | -8.04% | 3.4% | -1.17% |
Total Long-Term Assets | $2.225B | $2.174B | $2.071B |
YoY Change | 5.81% | 4.94% | 11.8% |
TOTAL ASSETS | |||
Total Short-Term Assets | $1.005B | $795.8M | $342.7M |
Total Long-Term Assets | $2.225B | $2.174B | $2.071B |
Total Assets | $3.229B | $2.970B | $2.414B |
YoY Change | 19.37% | 23.01% | 12.73% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $386.3M | $345.1M | $328.3M |
YoY Change | 9.21% | 5.12% | 1393.18% |
Accrued Expenses | $59.25M | $58.14M | $58.59M |
YoY Change | -0.43% | -0.77% | -9.73% |
Deferred Revenue | $4.462M | $4.475M | $4.343M |
YoY Change | -11.71% | 3.04% | |
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $24.22M | $20.20M | $15.94M |
YoY Change | 51.45% | 26.78% | 42.74% |
Total Short-Term Liabilities | $474.2M | $427.9M | $407.1M |
YoY Change | 9.2% | 5.1% | 6.78% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $1.002B | $814.4M | $852.4M |
YoY Change | 18.16% | -4.45% | 15.07% |
Other Long-Term Liabilities | $10.13M | $5.074M | $27.52M |
YoY Change | -55.69% | -81.56% | 271.88% |
Total Long-Term Liabilities | $1.013B | $819.5M | $879.9M |
YoY Change | 16.22% | -6.86% | 17.61% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $474.2M | $427.9M | $407.1M |
Total Long-Term Liabilities | $1.013B | $819.5M | $879.9M |
Total Liabilities | $2.137B | $1.892B | $1.921B |
YoY Change | 9.89% | -1.5% | 11.68% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$85.34M | -$82.36M | -$103.6M |
YoY Change | -10.41% | -20.53% | 14.81% |
Common Stock | $7.000K | $7.000K | $6.000K |
YoY Change | 0.0% | 16.67% | 20.0% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $881.0M | $873.0M | $327.9M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $3.229B | $2.970B | $2.414B |
YoY Change | 19.37% | 23.01% | 12.73% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 | 2023 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$2.982M | -$2.779M | -$21.01M |
YoY Change | -135.63% | -86.77% | -797.15% |
Depreciation, Depletion And Amortization | $34.48M | $32.37M | $31.32M |
YoY Change | 7.13% | 3.36% | 15.48% |
Cash From Operating Activities | $116.0M | $17.09M | $32.62M |
YoY Change | 70.41% | -47.62% | 3519.98% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $46.69M | $57.41M | $55.92M |
YoY Change | 18.3% | 2.67% | -252.95% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$30.66M | -$3.528M | -$9.641M |
YoY Change | 3348.26% | -63.41% | -61.45% |
Cash From Investing Activities | -$77.34M | -$60.94M | -$65.56M |
YoY Change | 91.66% | -7.05% | 6.48% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 176.1M | $228.3M | -$3.821M |
YoY Change | -26.04% | -6074.82% | 15.33% |
NET CHANGE | |||
Cash From Operating Activities | 116.0M | $17.09M | $32.62M |
Cash From Investing Activities | -77.34M | -$60.94M | -$65.56M |
Cash From Financing Activities | 176.1M | $228.3M | -$3.821M |
Net Change In Cash | 214.8M | $184.4M | -$36.99M |
YoY Change | -19.21% | -598.54% | -42.11% |
FREE CASH FLOW | |||
Cash From Operating Activities | $116.0M | $17.09M | $32.62M |
Capital Expenditures | $46.69M | $57.41M | $55.92M |
Free Cash Flow | $69.32M | -$40.32M | -$23.30M |
YoY Change | 142.29% | 73.07% | -162.2% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
12185000 | usd |
CY2024Q1 | us-gaap |
Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#InterestExpenseDebt | |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
431707000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
390564000 | usd |
CY2024Q1 | rdnt |
Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
|
387589000 | usd |
CY2023Q1 | rdnt |
Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
|
351865000 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
32368000 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
31315000 | usd |
CY2024Q1 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-186000 | usd |
CY2023Q1 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-579000 | usd |
CY2024Q1 | us-gaap |
Severance Costs1
SeveranceCosts1
|
225000 | usd |
CY2023Q1 | us-gaap |
Severance Costs1
SeveranceCosts1
|
134000 | usd |
CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
420368000 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
383893000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
11339000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
6671000 | usd |
CY2024Q1 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
16267000 | usd |
CY2023Q1 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
15722000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
4324000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
1428000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Fair Value Of Hedged Item In Interest Rate Fair Value Hedge1
IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
|
1216000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Fair Value Of Hedged Item In Interest Rate Fair Value Hedge1
IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
|
-4093000 | usd |
CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
2934000 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1432000 | usd |
CY2024Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-7793000 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-19819000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
3546000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-13148000 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1864000 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1135000 | usd |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
5410000 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-14283000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
8189000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
6722000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2779000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-21005000 | usd |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.36 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.36 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
69307078 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
69307078 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
57701439 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
57701439 | shares |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
5410000 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-14283000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-2198000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
2777000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
|
-739000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
|
-922000 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
3951000 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-10584000 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
8189000 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
6722000 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-4238000 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-17306000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
813359000 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
8000 | usd |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
11906000 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
218385000 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
4607000 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
|
9000 | usd |
CY2024Q1 | us-gaap |
Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
|
21191000 | usd |
CY2024Q1 | rdnt |
Noncontrolling Interest Increase Contribution From Noncontrolling Interest
NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest
|
3927000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
|
-2198000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
|
-739000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1077325000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
491452000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
51000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
|
2777000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
|
0 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
|
-922000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity Other
StockholdersEquityOther
|
3000 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-14283000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
493101000 | usd |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
5410000 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
32368000 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
31315000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
14711000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
15699000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
|
4324000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
|
1835000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
748000 | usd |
CY2023Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
746000 | usd |
CY2024Q1 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-186000 | usd |
CY2023Q1 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-579000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Deferred Hedge Gains
AmortizationOfDeferredHedgeGains
|
739000 | usd |
CY2023Q1 | us-gaap |
Amortization Of Deferred Hedge Gains
AmortizationOfDeferredHedgeGains
|
922000 | usd |
CY2024Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
1216000 | usd |
CY2023Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
-4093000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
11897000 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
12185000 | usd |
CY2024Q1 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
1974000 | usd |
CY2023Q1 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
2335000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
25865000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
9997000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
6277000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
1691000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
5892000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
2726000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
1158000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
-942000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-12883000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-15080000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-172000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
335000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
6839000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
9077000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
17085000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
32616000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Buildings
PaymentsToAcquireBuildings
|
3530000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Buildings
PaymentsToAcquireBuildings
|
9644000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
57409000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
55915000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
2000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
3000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-60937000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-65556000 | usd |
CY2024Q1 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
1102000 | usd |
CY2023Q1 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
184000 | usd |
CY2024Q1 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
1875000 | usd |
CY2023Q1 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
3688000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
|
4169000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
|
0 | usd |
CY2024Q1 | rdnt |
Proceeds From Sale Of Economic Interest In A Majority Owned Subsidiary
ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary
|
8713000 | usd |
CY2023Q1 | rdnt |
Proceeds From Sale Of Economic Interest In A Majority Owned Subsidiary
ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary
|
0 | usd |
CY2024Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
218385000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | usd |
CY2024Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
8000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
51000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
228298000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3821000 | usd |
CY2024Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-36000 | usd |
CY2023Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-229000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
184410000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-36990000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
342570000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
127834000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
526980000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
90844000 | usd |
CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
18285000 | usd |
CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
21471000 | usd |
CY2024Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1000 | usd |
CY2023Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
40000 | usd |
CY2024Q1 | rdnt |
Equipment Acquired And Leasehold Improvements
EquipmentAcquiredAndLeaseholdImprovements
|
44100000 | usd |
CY2023Q1 | rdnt |
Equipment Acquired And Leasehold Improvements
EquipmentAcquiredAndLeaseholdImprovements
|
40800000 | usd |
CY2024Q1 | rdnt |
Number Of Centers
NumberOfCenters
|
375 | center |
CY2024Q1 | us-gaap |
Variable Interest Entity Activity Between Vie And Entity Revenues
VariableInterestEntityActivityBetweenVIEAndEntityRevenues
|
52300000 | usd |
CY2023Q1 | us-gaap |
Variable Interest Entity Activity Between Vie And Entity Revenues
VariableInterestEntityActivityBetweenVIEAndEntityRevenues
|
48800000 | usd |
CY2024Q1 | us-gaap |
Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
|
52300000 | usd |
CY2023Q1 | us-gaap |
Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
|
48800000 | usd |
CY2024Q1 | us-gaap |
Variable Interest Entity Activity Between Vie And Entity Income Or Loss Before Tax
VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
|
234800000 | usd |
CY2023Q1 | us-gaap |
Variable Interest Entity Activity Between Vie And Entity Income Or Loss Before Tax
VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
|
207400000 | usd |
CY2024Q1 | rdnt |
Contracts Receivable Factoring Receivable
ContractsReceivableFactoringReceivable
|
12100000 | usd |
CY2023Q4 | rdnt |
Contracts Receivable Factoring Receivable
ContractsReceivableFactoringReceivable
|
14300000 | usd |
CY2024Q1 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
1500000 | usd |
CY2023Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
1600000 | usd |
CY2024Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.526 | |
CY2024Q1 | us-gaap |
Goodwill
Goodwill
|
694300000 | usd |
CY2023Q4 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
CY2023Q4 | us-gaap |
Goodwill
Goodwill
|
679463000 | usd |
CY2024Q1 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
16156000 | usd |
CY2024Q1 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
1327000 | usd |
CY2024Q1 | us-gaap |
Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
|
0 | usd |
CY2024Q1 | us-gaap |
Goodwill
Goodwill
|
694292000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
9253000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
12068000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
11619000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
10613000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
10472000 | usd |
CY2024Q1 | rdnt |
Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
|
32858000 | usd |
CY2024Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
86883000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
12645000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
12283000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
11833000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
10818000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
10505000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
32531000 | usd |
CY2023Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
90615000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
3200000 | usd |
CY2023Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
3000000 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1900000 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1100000 | usd |
CY2023Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.086 | |
CY2024Q1 | rdnt |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
|
1 | incentiveplan |
rdnt |
Monthly Amortization Of Deferred Hedge Gains
MonthlyAmortizationOfDeferredHedgeGains
|
400000 | usd | |
CY2024Q1 | us-gaap |
Debt Instrument Fair Value
DebtInstrumentFairValue
|
821187000 | usd |
CY2023Q4 | us-gaap |
Debt Instrument Fair Value
DebtInstrumentFairValue
|
823063000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2779000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-21005000 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
69307078 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
69307078 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
57701439 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
57701439 | shares |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.36 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.36 | |
CY2024Q1 | rdnt |
Fair Value Change For Contingently Available Shares Excluded From Computation Of Diluted
FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted
|
0 | usd |
CY2023Q1 | rdnt |
Fair Value Change For Contingently Available Shares Excluded From Computation Of Diluted
FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted
|
769000 | usd |
CY2024Q1 | rdnt |
Equity Securities Without Readily Determinable Fair Value Number Of Securities
EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities
|
4 | security |
CY2024Q1 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
9200000 | usd |
CY2024Q1 | rdnt |
Numberof Unconsolidated Joint Ventures
NumberofUnconsolidatedJointVentures
|
13 | jointventure |
CY2023Q4 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
92710000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
4324000 | usd |
CY2024Q1 | us-gaap |
Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
|
0 | usd |
CY2024Q1 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
97034000 | usd |
CY2024Q1 | rdnt |
Management Service Fees
ManagementServiceFees
|
5900000 | usd |
CY2023Q1 | rdnt |
Management Service Fees
ManagementServiceFees
|
4200000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
6.30 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
910411 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
16.61 | |
CY2024Q1 | us-gaap |
Revenues
Revenues
|
431707000 | usd |
CY2023Q1 | us-gaap |
Revenues
Revenues
|
390564000 | usd |
CY2024Q1 | us-gaap |
Revenues
Revenues
|
431707000 | usd |
CY2023Q1 | us-gaap |
Revenues
Revenues
|
390564000 | usd |
CY2024Q1 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
387589000 | usd |
CY2023Q1 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
351865000 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
32368000 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
31315000 | usd |
CY2024Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-186000 | usd |
CY2023Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-579000 | usd |
CY2024Q1 | us-gaap |
Severance Costs1
SeveranceCosts1
|
225000 | usd |
CY2023Q1 | us-gaap |
Severance Costs1
SeveranceCosts1
|
134000 | usd |
CY2024Q1 | rdnt |
Operating Income Loss Excluding Relief Funding
OperatingIncomeLossExcludingReliefFunding
|
11339000 | usd |
CY2023Q1 | rdnt |
Operating Income Loss Excluding Relief Funding
OperatingIncomeLossExcludingReliefFunding
|
6671000 | usd |
CY2024Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
834644000 | usd |
CY2023Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
830042000 | usd |
CY2024Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
20202000 | usd |
CY2023Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
17974000 | usd |
CY2024Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
814442000 | usd |
CY2023Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
812068000 | usd |
CY2024Q1 | rdnt |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
|
1 | incentiveplan |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
20100000 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
911411 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
16.60 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
CY2024Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
1000 | shares |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y11M4D | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
29178798000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
789112 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
15.83 | |
CY2024Q1 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
|
P5Y6M10D | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
25907138000 | usd |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
20100000 | shares |
CY2024Q1 | us-gaap |
Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
|
3323670 | shares |
CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |